Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    " April 07, 2013":" May 07, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients
Condition: Chronic Infection With HIV
Interventions: Drug: Ritonavir boosted Atazanavir;   Drug: Raltegravir;   Drug: TDF/FTC (or 3TC)
2 Enrolling by invitation The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling
Condition: HIV Infection
Intervention: Other: Self-Collected HPV Test
3 Completed Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection
Condition: HIV
Interventions: Dietary Supplement: Prebiotics+Glutamine;   Dietary Supplement: Placebo
4 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
5 Unknown  Immune Activation and Drug Absorption in HIV-Infected Patients
Condition: HIV Infection
Intervention: Drug: Rifampicin 600 mg
6 Recruiting Lactoferrin Treatment in HIV Patients
Condition: HIV Infection
Interventions: Drug: Recombinant Lactoferrin;   Drug: Placebo
7 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
8 Active, not recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
9 Completed
Has Results
Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy
Condition: HIV-associated Enteropathy
Interventions: Other: Serum-derived bovine immunoglobulin protein isolate (SBI);   Other: Placebo
10 Completed Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia
Condition: HIV
Intervention: Device: PrePex
11 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
12 Completed An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Condition: HIV-associated Lipodystrophy Syndrome
Interventions: Drug: GSK1265744B (sodium salt) containing 14C-GSK1265744B;   Drug: 150 mg GSK1265744B;   Drug: Placebo
13 Completed Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome (AIDS)
Intervention: Other: Questionnaire
14 Completed Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV
Condition: HIV
Intervention: Behavioral: Aerobic and Strength Training Intervention
15 Recruiting Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
Condition: HIV
Interventions: Biological: pSG2.HIVconsv DNA vaccine;   Biological: ChAdV63.HIVconsv booster vaccine;   Biological: MVA.HIVconsv booster vaccine;   Drug: CPHPC;   Other: Placebo
16 Recruiting HIV Non-Occupational Post-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus
Intervention: Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)
17 Completed
Has Results
Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat
Condition: Human Immunodeficiency Virus Type 1 (HIV-1)
Interventions: Drug: Atazanavir;   Drug: Cobicistat;   Drug: Atazanavir/Cobicistat FDC
18 Withdrawn Project TEACH-Kenya
Condition: HIV
Intervention: Behavioral: Risk Reduction Intervention
19 Completed
Has Results
A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers
Condition: HIV
Interventions: Drug: Raltegravir;   Drug: Amlodipine
20 Active, not recruiting Pilot Study of Lubiprostone as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Persons With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Condition: HIV
Intervention: Drug: Lubiprostone

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.